FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Noven Pharmaceuticals Xelstrym Recall

Xelstrym (dextroamphetamine) transdermal system, 13

Noven Pharmaceuticals Inc · Miami, FL

Risk level
Class II
Reported by FDA
Nov 27, 2024
Recall ID
D-0055-2025
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Xelstrym starting Oct 31, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0055-2025 on Nov 27, 2024. Reason: Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive). Status: Ongoing.

Why it was recalled

Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

Product description

Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3

Lot numbers, UPCs & expiration codes

Lot # 95598, Exp 02/28/25

Where it was sold

USA nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0055-2025
Classification
Class II
Status
Ongoing
Recall initiated
Oct 31, 2024
FDA report date
Nov 27, 2024
Quantity
685 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0055-2025, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Ongoing
Country
United States
Event ID
95701
Address
11960 Sw 144th St
Code information
Lot # 95598, Exp 02/28/25
Postal code
33186-6109
Report date
Nov 27, 2024
Product type
Drugs
Recall number
D-0055-2025
Classification
Class II
Recalling firm
Noven Pharmaceuticals Inc
Product quantity
685 boxes
Reason for recall
Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3
Distribution pattern
USA nationwide.
Recall initiation date
Oct 31, 2024
Initial firm notification
Letter
Center classification date
Nov 19, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0055-2025, published Nov 27, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls